News

Lightspeed Venture Partners and Sutter Hill Ventures led the round with participation from Clarus Ventures and GV (formerly Google Ventures). Forty Seven has also licensed the rights from

The research project will assess the feasibility of using a novel, patent-pending lymph directing drug delivery technology. The technology was developed by researchers at the ARC Centre of

At Week 48, the F/TAF-based regimens were found to be statistically non-inferior to the F/TDF-based regimens, based on percentages of patients with HIV-1 RNA levels less than 50

University of Washington, the Seattle Cancer Care Alliance (SCCA), Fred Hutch, and Juno are all investing in the CTU, and Juno will also provide research funds to Fred

Makena is indicated to lower the risk of preterm birth in women who are pregnant with one baby and who have spontaneously delivered one preterm baby earlier. The

In its refuse to file letter, the agency stated that PTC’s application was insufficient to permit a substantive review. The company said it is reviewing its content to

Researchers at Texas Children’s Hospital and Houston Methodist Hospital developed the test that identifies the genetic material of the Zika virus. The tests, which can be carried out

Patheon was selected to assist with the development of advanced INTAC based products including single-entity and fixed-dose combination solid oral dosage forms with immediate and modified release properties.

Under the collaboration, Rockland will provide and manage Formula’s specially hired preclinical research team. Further, Rockland will provide the classified research facilities for Formula’s preclinical development needs in